Trial Outcomes & Findings for Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm (NCT NCT01632267)
NCT ID: NCT01632267
Last Updated: 2016-01-05
Results Overview
Number of outpatient healthcare visits during study window
Recruitment status
COMPLETED
Target enrollment
104 participants
Primary outcome timeframe
During the one year study window (April 1, 2010 to April 1, 2011)
Results posted on
2016-01-05
Participant Flow
Participant milestones
| Measure |
Depression and Anxiety
Subjects with a primary diagnosis of depression or anxiety disorder.
|
|---|---|
|
Overall Study
STARTED
|
104
|
|
Overall Study
COMPLETED
|
97
|
|
Overall Study
NOT COMPLETED
|
7
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Retrospective Analysis of Outcomes With a Pharmacogenomic Algorithm
Baseline characteristics by cohort
| Measure |
Depression and Anxiety
n=104 Participants
Subjects with a primary diagnosis of depression or anxiety disorder.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
97 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
7 Participants
n=5 Participants
|
|
Age, Continuous
|
50.9 years
STANDARD_DEVIATION 11.9 • n=5 Participants
|
|
Sex: Female, Male
Female
|
68 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
36 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
104 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: During the one year study window (April 1, 2010 to April 1, 2011)Number of outpatient healthcare visits during study window
Outcome measures
| Measure |
Depression and Anxiety
n=97 Participants
Subjects with a primary diagnosis of depression or anxiety disorder.
|
|---|---|
|
Number of Outpatient Visits
|
13 units on a scale
Standard Deviation 9.4
|
SECONDARY outcome
Timeframe: During the one year study window (April 1, 2010 to April 1, 2011)Number of medical absence days during study window
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: During the one year study window (April 1, 2010 to April 1, 2011)Number of disabiity claims during study window
Outcome measures
Outcome data not reported
Adverse Events
Depression and Anxiety
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place